Literature DB >> 8481394

Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II.

K A Rye1, K H Garrety, P J Barter.   

Abstract

This study describes the preparation of spheroidal reconstituted HDL which contain apolipoprotein (apo) A-I only, (A-I w/o A-II) r-HDL, or apo A-I and apo A-II, (A-I w A-II) r-HDL. Spheroidal (A-I w/o A-II) r-HDL with diameters of 8.0, 9.2 and 11.2 nm were prepared by incubating discoidal (A-I w/o A-II) r-HDL with lecithin-cholesterol acyltransferase and low-density lipoproteins. Spheroidal (A-I w A-II) r-HDL were prepared by displacing apo A-I from spheroidal (A-I w/o A-II) r-HDL with apo A-II. Modification with apo A-II did not significantly affect the diameters of the 8.0 and 9.2 nm (A-I w/o A-II) r-HDL. When, however, apo A-II was added to the (A-I w/o A-II) r-HDL of diameter 11.2 nm, the size of the particles decreased to 9.4 nm. To determine whether modification of (A-I w/o A-II) r-HDL with apo A-II altered the structure of the r-HDL, the packing of phospholipids in the modified and unmodified particles was compared by steady state fluorescence polarization and the environments of the apo A-I tryptophan residues in (A-I w/o A-II) and (A-I w A-II) r-HDL were compared by fluorescence spectroscopy. The results of these studies suggested that modification of spheroidal (A-I w/o A-II) r-HDL with apo A-II alters the environment of apo A-I tryptophan residues in small, but not large, r-HDL and does not affect the packing of phospholipids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481394     DOI: 10.1016/0005-2760(93)90235-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Speciated human high-density lipoprotein protein proximity profiles.

Authors:  Kekulawalage Gauthamadasa; Corina Rosales; Henry J Pownall; Stephen Macha; W Gray Jerome; Rong Huang; R A Gangani D Silva
Journal:  Biochemistry       Date:  2010-11-23       Impact factor: 3.162

2.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

Authors:  Giorgio Cavigiolio; Baohai Shao; Ethan G Geier; Gang Ren; Jay W Heinecke; Michael N Oda
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

3.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

4.  The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.

Authors:  E Nobecourt; M J Davies; B E Brown; L K Curtiss; D J Bonnet; F Charlton; A S Januszewski; A J Jenkins; P J Barter; K-A Rye
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

5.  HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.

Authors:  Fatiha Tabet; Kasey C Vickers; Luisa F Cuesta Torres; Carrie B Wiese; Bassem M Shoucri; Gilles Lambert; Claire Catherinet; Leonel Prado-Lourenco; Michael G Levin; Seth Thacker; Praveen Sethupathy; Philip J Barter; Alan T Remaley; Kerry-Anne Rye
Journal:  Nat Commun       Date:  2014-02-28       Impact factor: 14.919

6.  Fenitrothion-induced structural and functional perturbations in the yolk lipoproteins of the shrimp Macrobrachium borellii.

Authors:  Fernando García; María R Gonzalez-Baró; Horacio Garda; Monica Cunningham; Ricardo Pollero
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

7.  Structure of spheroidal HDL particles revealed by combined atomistic and coarse-grained simulations.

Authors:  Andrea Catte; James C Patterson; Denys Bashtovyy; Martin K Jones; Feifei Gu; Ling Li; Aldo Rampioni; Durba Sengupta; Timo Vuorela; Perttu Niemelä; Mikko Karttunen; Siewert Jan Marrink; Ilpo Vattulainen; Jere P Segrest
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

8.  Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.

Authors:  E Nobécourt; J Zeng; M J Davies; B E Brown; S Yadav; P J Barter; K-A Rye
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

9.  Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.

Authors:  Bronwyn E Brown; Estelle Nobecourt; Jingmin Zeng; Alicia J Jenkins; Kerry-Anne Rye; Michael J Davies
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis.

Authors:  Belinda A Di Bartolo; Siân P Cartland; Scott Genner; Pradeep Manuneedhi Cholan; Melissa Vellozzi; Kerry-Anne Rye; Mary M Kavurma
Journal:  J Diabetes Res       Date:  2021-05-06       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.